Levitee Labs Inc. (LVTTF) Research

Levitee Labs Inc. is a holistic wellness enterprise dedicated to providing advanced, evidence-backed alternative treatments, including innovative psychedelic therapies. The company's operations are structured into two primary divisions: Medical Services and Product Sales. Through these, Levitee Labs delivers a range of treatments and medications addressing a broad spectrum of conditions such as substance addiction, various forms of chronic pain (including myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome), hepatitis-C, and mental health challenges. Its physical network encompasses five "Levitee Clinics" and three "Levitee Pharmacies," the latter operating specifically within Alberta. Additionally, Levitee Labs extends its reach by offering electronic prescription services for addiction treatment via its BlockMD platform and engaging in the wholesale distribution of supplements and superfoods under the Earth Circle Organics brand. Incorporated in 2019, the company, originally known as Fibonacci Capital Corp. until its rebranding as Levitee Labs Inc. on November 30, 2020, maintains its headquarters in Vancouver, Canada.

Market snapshot

Symbol
LVTTF
Price
$0.00
Day change
0.00%
Market cap
$502.1K
P/E ratio
-0.03x
52-week range
0.000001-0.0027
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • CannAmerica Brands Corp. (CNNXF)
  • CuraScientific Corp (CSTF)
  • Global Hemp Group Inc. (GBHPF)
  • Industry Source Consulting, Inc. (INSO)
  • Legacy Technology Holdings, Inc. (LTHO)
  • Maple Leaf Green World Inc. (MGWFF)
  • Real Brands, Inc. (RLBD)
  • Sky Century Investment, Inc. (SKYI)

Open Levitee Labs Inc. (LVTTF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.